Evidence map›Paper›PMID 31647348›Full record

ArticleHuman vaccines & immunotherapeutics2020

Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulations.

Ruprecht Schmidt-Ott, Daniel Molnar, Anastassia Anastassopoulou, Emad Yanni, Claudia Krumm, Rafik Bekkat-Berkani, Gaël Dos Santos, Philipp Henneke, Markus Knuf, Markus Schwehm and 1 more

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ruprecht Schmidt-OttGSK, Wavre, Belgium.
Daniel MolnarGSK, Wavre, Belgium.
Anastassia AnastassopoulouGSK, Munich, Germany.
Emad YanniGSK, Rockville, MD, USA.ORCID 0000-0001-9026-0735
Claudia KrummGSK, Munich, Germany.
Rafik Bekkat-BerkaniGSK, Philadelphia, PA, USA.
Gaël Dos SantosGSK, Wavre, Belgium.ORCID 0000-0001-8623-3478
Philipp HennekeCenter for Chronic Immunodeficiency and Center for Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Markus KnufHelios Dr Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
Markus SchwehmExploSYS GmbH, Leinfelden-Echterdingen, Germany.
Martin EichnerEpimos GmbH, Dusslingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Children have a high burden of influenza and play a central role in spreading influenza. Routinely vaccinating children against influenza may, thus, not only reduce their disease burden, but also that of the general population, including the elderly who frequently suffer severe complications. Using the published individual-based tool 4Flu, we simulated how pediatric vaccination would change infection incidence in Germany. Transmission of four influenza strains was simulated in 100,000 individuals with German demography and contact structure. After initialization with the recorded trivalent influenza vaccination coverage for 20 years (1997-2016), all vaccinations were switched to quadrivalent influenza vaccine (QIV). Scenarios where vaccination coverage of children (0.5-17-year-old) was increased from the current value (4.3%) to a maximum of 10-60% were compared to baseline with unchanged coverage, averaging results of 1,000 pairs of simulations over a 20-year evaluation period (2017-2036). Pediatric vaccination coverage of 10-60% annually prevented 218-1,732 (6.3-50.5%) infections in children, 204-1,961 (2.9-28.2%) in young adults and 95-868 (3.1-28.9%) in the elderly in a population of 100,000 inhabitants; overall, 34.1% of infections in the total population (3.7 million infections per year in Germany) can be prevented if 60% of all children are vaccinated annually. 4.4-4.6 vaccinations were needed to prevent one infection among children; 1.7-1.8 were needed to prevent one in the population. Enhanced pediatric vaccination prevents many infections in children and even more in young adults and the elderly.

Indexed as

Influenza, HumanInfluenza VaccinesAdolescentAgedChildChild, PreschoolGermanyHumansInfantVaccinationVaccination CoverageYoung AdultInfluenza VaccinesInfluenzamathematical modelpediatricsimulationvaccination

Identifiers

PMID31647348
PMCPMC7227695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.